NBA: 5 takeaways from Derrick Rose signing with Cleveland Cavaliers
2. Rose a low-risk investment for Cavs
Rose has had more than his share of misfortune when it comes to injuries. After missing 27 games during the 2011-12 season, he tore his left ACL in the playoffs, forcing him to sit out the following season.
During the 2013-14 campaign, the injury bug reared its head again, as Rose tore the meniscus in his right knee in a road game against the Portland Trail Blazers, forcing the former MVP to miss the remainder of that season.
The injury trend continued for Rose in 2014-15. In that season, he missed a total of 31 games, including the final 20 games due to a second meniscus tear. And if all that wasn’t bad enough, Rose missed the final few games of the 2016-17 season due to meniscus tear in his left knee.
Needless to say, Rose is considered damaged goods at this point, and there are very few teams that would be willing to offer him a huge contract given his durability issues. But in spite of the injuries that have plagued his career over the past several seasons, Rose had somewhat of a bounce-back season with the Knicks last season.
His 18 points per contest were the highest since 2011-12. In addition to that, he shot 47 percent from the field — the third-highest mark of his career.
If Rose has a great year, then the Cavs definitely will get their money’s worth. Conversely, if Rose stinks up the joint, the Cavs can simply explore other options at the end of next season.
Either way you look at it, this is a low-risk move for all parties involved.